What kind of doctor treats Restless Legs in Australia?
Your GP is the right first stop, and for most people the only one. Restless Legs Syndrome is a clinical diagnosis, made on your symptom pattern rather than a test result, according to the Royal Australian College of General Practitioners (Nanayakkara, Di Michiel & Yee, 2023, Australian Journal of General Practice).
Sleep physicians and neurologists come later, and only for specific reasons. That is good news if you have been putting the appointment off because you assumed you needed a referral, a sleep study and a six-month wait. You do not. A GP who recognises the pattern can start the work-up on the day.
It helps to know what the pattern is, because your GP will be listening for it. Five features define Restless Legs (Nanayakkara et al., 2023):
- An urge to move the legs, usually with an uncomfortable or unpleasant sensation.
- Symptoms that begin or worsen at rest, sitting or lying down.
- Relief while you are actually moving, for as long as you keep moving.
- Symptoms worse in the evening or overnight rather than during the day.
- No other obvious explanation, such as cramps, arthritis or leg swelling.
If you can describe your nights in those terms, you have done half the diagnostic work already.
One caution worth carrying in. Restless Legs has plenty of look-alikes, and the same review lists leg cramps, positional discomfort, aching legs, venous problems, swelling, arthritis and habitual foot tapping among them. A GP ruling those out is doing the job properly, not brushing you off.
What to ask your GP about Restless Legs
Going in with a short list of requests changes the appointment from a vague complaint about bad sleep into a work-up with a plan. These are the five worth writing down:
- “Can I have fasting iron studies, including ferritin and transferrin saturation?” This is the one test that changes management most often. Ask for it fasting, and ask for the actual numbers rather than “normal”.
- “Can we check my full blood count and kidney function too?” The Australian Journal of General Practice review recommends these alongside iron studies, because kidney disease is a known driver (Nanayakkara et al., 2023).
- “Could any of my current medicines be making this worse?” Sedating antihistamines, SSRIs, SNRIs and dopamine-blocking anti-nausea medicines such as metoclopramide are all named as common culprits in the same review. Mirtazapine shows the strongest association among antidepressants.
- “What are my options that are not a dopamine agonist?” Ask this early. It saves an awkward conversation two years from now, and the reasons are set out in the next section.
- “What should I do in the meantime, at 2am, tonight?” Most people never ask. It is the question that gets you something usable before any test results come back.
Write the list on your phone. Ten minutes goes faster than you think, and the iron studies request is the one that must not get lost.
What Medicare covers for a Restless Legs work-up in Australia
Medicare covers the blood tests, the GP consultation and, when it is warranted, the specialist referral. It does not cover supplements, compression garments, or devices you buy yourself. The iron studies your GP orders sit under Medicare Benefits Schedule item 66596. That item covers serum iron, transferrin or iron binding capacity, and ferritin together.
The numbers on that item, checked on MBS Online in September 2026, are a schedule fee of $32.55 with a benefit of 85 per cent, or $27.70. Whether that leaves you out of pocket depends on whether your clinic and its pathology lab bulk bill.
Bulk billing varies from practice to practice, so it is a fair question to ask the receptionist when you book.
You can claim a Medicare benefit on the GP consultation itself as well, so the same bulk-billing question applies there. If your practice does not bulk bill, booking a longer appointment usually costs more but is worth it here, because Restless Legs is genuinely hard to cover properly in a six-minute slot.
Do not expect to be sent for a sleep study. Overnight sleep testing is not routinely used to diagnose Restless Legs, because the diagnosis is made on symptoms (Nanayakkara et al., 2023).
If one is ordered, it is usually because your GP suspects something else is going on as well, such as sleep apnoea. That is a reasonable thing to check and worth agreeing to.
What your GP may prescribe, and why the guidance changed
Knowing what has changed in the prescribing guidance stops you feeling blindsided, either now or in three years. The 2024 American Academy of Sleep Medicine guideline (Winkelman et al., 2024) makes a conditional recommendation against routine ongoing use of the dopamine agonists ropinirole and pramipexole, sold in Australia as Sifrol.
If a medicine is warranted, the guideline points first to gabapentin enacarbil, gabapentin or pregabalin instead.
If you have been on a dopamine agonist for years and the legs are creeping earlier into the evening, that has a name: augmentation. It is the medicine that helped at first gradually making things worse. Australian guidance has moved the same way, and the numbers explain why.
The numbers are not small. The Australian Journal of General Practice review puts augmentation at roughly 40 to 70 per cent over ten years with pramipexole and ropinirole (Nanayakkara et al., 2023). The same review puts impulse control problems, such as compulsive gambling or shopping, at 6 to 17 per cent, appearing on average nine months in.
If that is already happening to you, our piece on Restless Legs augmentation explains what to say at the next appointment.
There is an Australian wrinkle here that catches people out. Pramipexole is the only one of these medicines listed on the Pharmaceutical Benefits Scheme for Restless Legs. Ropinirole and the rotigotine patch are TGA-listed but not PBS-listed for it.
You may pay full price for the medicines now recommended first. The gabapentin-type drugs are not TGA-approved or PBS-listed for Restless Legs in Australia, so prescribing them is off-label. That is a normal, legal thing for a GP to do, and it is worth discussing upfront rather than at the chemist.
We compare the two drug classes in detail in gabapentin versus ropinirole, and cover the broader trade-offs in Restless Legs medication side effects.
When you actually get referred to a specialist
Most people never need a referral, and the ones who do get sent for clear reasons rather than as a formality. The Australian Journal of General Practice review names two in particular (Nanayakkara et al., 2023). Specialist consultation is recommended if augmentation develops, and referral to a sleep physician or neurologist is recommended before any opioid is started.
A referral is also reasonable if the diagnosis itself is unclear, if there is a suspected nerve problem, or if symptoms started very young. In Australia you need a GP referral for the Medicare rebate on a specialist appointment, so the GP visit is not a step you can skip anyway.
For a fuller picture of what is available locally, see our guide to Restless Legs treatment in Australia.
What the research actually shows
You can walk into the appointment knowing what the evidence actually supports, which makes it much easier to ask for the right things. Three findings matter most for an Australian GP conversation about Restless Legs.
Iron is the first lever, and your ferritin number matters more than “normal”. Australian guidance targets a ferritin above 75 micrograms per litre, or transferrin saturation above 20 per cent (Nanayakkara, Di Michiel & Yee, 2023, Australian Journal of General Practice). Improvement after starting iron can take one to three months.
A result inside the standard lab reference range can still be too low for Restless Legs purposes, which is exactly why you ask for the number. We go deeper in iron, ferritin and Restless Legs.
Brain iron and blood iron are not the same thing. The same review notes that serum iron deficiency shows up in only 25 to 44 per cent of people with Restless Legs, with the stronger evidence pointing to iron in the brain.
So a normal blood result does not mean iron is irrelevant, and it does not mean you are imagining the nights.
Compression has controlled evidence behind it, which is unusual for a non-drug option. Lettieri and Eliasson (2009), published in Chest, ran a randomised, double-blinded, sham-controlled trial in 35 adults. They recorded a 40 per cent reduction in symptom severity, with scores falling from 14.1 to 8.4 on the international severity scale.
That was not a placebo story. Roughly a third of people using the real device reported complete relief, against none in the sham group. It is still one small trial, not a guarantee. It is fair to mention to your GP as something you are trying alongside their plan rather than instead of it.
What Stillr is, and isn’t
Stillr is a compression sleeve worn overnight, applying targeted pressure to the area research shows responds to it. It is not a medicine and not a replacement for the GP appointment described above. It is drug-free, has no electronics and no batteries, and is worn on both legs while you sleep. Stillr is pre-launch, at a flat AUD $169 per pair with free tracked shipping in Australia. It comes with a 60-Night Sleep Trial: full refund if it does not improve your sleep, return postage covered. Designed in Australia.
Book the appointment, ask for the ferritin number, and start there. If you want something drug-free on your own terms while you work through the medical side, you can reserve your pair at stillr.com.au or join the founders’ list.